Evelo Biosciences Sees Unusually High Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the recipient of some unusual options trading activity on Wednesday. Stock investors acquired 1,885 put options on the company. This is an increase of 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Stock Performance

The business’s 50 day moving average price is $0.03 and its 200 day moving average price is $0.04. Evelo Biosciences has a 52 week low of $0.00 and a 52 week high of $13.93. The stock has a market cap of $2,000.00, a price-to-earnings ratio of 0.00 and a beta of 1.58.

Institutional Trading of Evelo Biosciences

A hedge fund recently raised its stake in Evelo Biosciences stock. Vanguard Group Inc. boosted its position in Evelo Biosciences, Inc. (NASDAQ:EVLO) by 129.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 357,711 shares of the company’s stock after purchasing an additional 201,815 shares during the quarter. Vanguard Group Inc. owned about 1.88% of Evelo Biosciences worth $1,402,000 at the end of the most recent reporting period. 0.31% of the stock is currently owned by institutional investors.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.